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Radiofrequency ablation (RFA) is widely used for
patients with hepatocellular carcinoma (HCC). The
reported complications of RFA include fever, pain,
peritoneal hemorrhage, bile duct injury, bowel perfo-
ration, liver abscess and cancer seeding along the
electrode tract [1]. Vascular injury resulting in liver
infarction is rare, with an incidence ranging from
0.07% to 2.3% [2]. Injury of large vessels with massive
liver infarction is even rarer, because heat can be
readily dissipated by convection of the blood flow
[3]. We report a man aged 64 years who developed
infarction of the left lateral sector of the liver after
sequential treatment with percutaneous pure ethanol
injection (PEI) and RFA for HCC. We discuss the
underlying mechanism of this complication and
review the literature.
CASE PRESENTATION
A man aged 64 years with hepatitis C virus-related
cirrhosis was admitted for treatment of residual HCC
after PEI. He had previously undergone transcatheter
arterial embolization (TAE) for bilateral HCC in
October 2006. Tumor recurrence in the left lateral sec-
tor of the liver, close to the umbilical portion of the
left portal vein, was found in March 2007. The tumor
was initially treated with PEI; however, a follow-up
abdominal computed tomography (CT) scan with con-
trast enhancement performed in April still showed a
residual tumor (Figure 1, black arrow).
As incomplete tumor ablation was considered, 
he was admitted for RFA treatment approximately 
1 month after the previous PEI treatment. On admis-
sion, his serum aspartate aminotransferase (AST) was
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Hepatic infarction is a rare complication of radiofrequency ablation (RFA) for hepatocellular car-
cinoma. Hepatic infarction is thought to be caused by injury to either the hepatic arterial system
or to both the hepatic arterial and portal venous supply. The efficacy of RFA is reduced in the pres-
ence of nearby vessels larger than 3 mm in diameter due to a heat-sink effect. Such an effect can
be diminished by performing percutaneous pure ethanol injection prior to RFA. Although larger
vessels are unlikely to be ablated or obliterated by RFA alone, it can happen and cause massive
liver damage, particularly if RFA was preceded by other therapies such as percutaneous pure
ethanol injection and/or transcatheter arterial embolization. Here, we report a case of massive
liver infarction after sequential use of both treatment modalities for hepatocellular carcinoma.
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63 U/L (normal, 0–54 U/L), alanine aminotransferase
(ALT) was 70 U/L (normal, 0–34 U/L), total bilirubin
was 15.3 μmol/L (normal, 3.4–23.8 μmol/L), and α-
fetoprotein was 38.72 ng/mL (normal, 0–20 ng/mL).
RFA was performed using an internally cooled elec-
trode with a 3-cm active tip (Cool-tip; Valleylab,
Boulder, CO, USA). The ablation time was 6 minutes
and the final temperature detected at the tip of the
electrode was 84°C.
The serum biochemical test on the first day after
RFA revealed: AST of 2,874 U/L; ALT of 2,186 U/L;
and total bilirubin of 42.5 μmol/L. However, he had
only mild fever and vague epigastric discomfort and
was discharged 3 days after RFA.
One month later, a follow-up blood test revealed
that the serum AST and ALT levels had returned to
69 U/L and 62 U/L, respectively, and total bilirubin
was 18.7 μmol/L. In addition, serum α-fetoprotein
level had also decreased to 28.4 ng/mL. The follow-
up CT imaging unexpectedly showed a large unen-
hanced area that was representative of infarcted liver
parenchyma involving the entire left lateral sector,
along with obliteration of the left portal vein branches
(Figure 2). Four months after RFA, the liver infarct
had decreased in size on CT imaging (Figure 3).
DISCUSSION
Hepatic infarction is an uncommon complication of RFA
and is diagnosed by the presence of a well-demarcated,
low-attenuated, peripheral, wedge-shaped area on
contrast CT imaging [2]. Hepatic infarction mainly
results from insults to the hepatic artery supply or to
both hepatic arterial and portal venous systems.
Older patients, or those with larger tumors, are at
risk of such complications [2]. Older patients have
aged arterial systems that are prone to thermal injury.
A larger tumor encases more liver segments and in-
creases the risk of vascular injury during RFA. The
main clinical features of hepatic infarction overlap
with those of post-ablation syndrome, including
fever, abdominal pain and malaise. Laboratory bio-
chemistry only reveals nonspecific findings such as
elevated aminotransferase levels caused by hepatic
Figure 2. Three weeks after radiofrequency ablation, a well-
demarcated, low-attenuated area involving the entire left lateral
sector of the liver as well as the absence of left portal vein
branches was depicted on contrast computed tomography.
Figure 1. Computed tomography shows a 2.1-cm tumor in the
left lateral sector (black arrow) of the liver. The tumor was close to
the umbilical portion of the left portal vein (white arrow, 7 mm in
diameter), which was slightly enhanced after contrast injection.
Figure 3. Computed tomography showing that the left lateral
sector of the liver had become shrunken 4 months after the local
ablation therapy.
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necrosis [2]. According to a report by Kim et al, the
serum levels of AST and ALT were similar between
patients who underwent RFA with and without liver
infarction, and the mean levels of AST and ALT after
RFA were approximately 10-fold higher than the pre-
ablation values [2]. Although our patient did not
have severe abdominal pain or signs of liver decom-
pensation, the extremely high serum levels of AST
and ALT (> 30-fold elevation) should have aroused
suspicion of massive liver infarction related to local
ablation therapy.
The presence of large vessels (i.e. > 3 mm in diam-
eter) adjacent to hepatic tumors will dissipate heat
away from tissue during RFA, the so called “heat-sink”
effect, and result in incomplete tumor necrosis [3]. To
avoid incomplete tumor ablation, reduction of the
vascular inflow to the liver using balloon catheter oc-
clusion [4] or surgical clamping (i.e. the Pringle maneu-
ver) is helpful [5]. Balloon occlusion of the hepatic
artery or portal vein, however, is an invasive proce-
dure and carries a high risk of post-occlusion portal
thrombosis and subsequent liver atrophy [4]. The
Pringle maneuver, involving directly clamping the
hepatic inflow vessels, can be applied safely to a nor-
mal liver for up to 1 hour; however, the need for
laparotomy or laparoscopy markedly increases the
invasiveness on the RFA procedure [5]. PEI can cause
coagulation and obliteration of small intratumoral
vessels, reduce the convection of blood flow and, there-
fore, eliminate the heat-sink effect of large vessels [6].
In addition, the heated ethanol may have an additional
effect in extending the area of tissue necrosis [7]. Con-
sequently, combined treatment with PEI and RFA for
HCC is recommended if the heat-sink effect is a con-
cern. The efficacy and safety of combination therapy
has been confirmed without hepatic infarction [7].
Lu et al evaluated the effect of vessel size on the
heat-sink effect in piglets, and found that no vessel
greater than 3 mm became thrombosed or occluded
after RFA [8]. In our case, although the CT imaging be-
fore RFA did not show any thrombi in the portal vein
and the diameter of the left portal vein branch near to
the hepatic tumor was 7 mm (Figure 1, white arrow),
the branch of the portal vein was still completely
obliterated after RFA. Portal vein thrombosis can be a
delayed complication of PEI, occurring 2 months after
the procedure [9]. The left portal vein branch or even
the left hepatic artery of this patient may have been
damaged solely by RFA. However, it is also possible
that these vessels were already compromised by PEI or
TAE and were then completely obliterated by further
RFA, which explains the high intratumor temperature
after a relatively short duration of RFA.
Because of the advent of multiple treatment
modalities, patients with HCC may undergo various
local ablation therapies as well as TAE. Although these
treatment modalities have been shown to be safe, un-
expected complications may occur when combining
them. In this case, the liver reserve of the patient was
good and no liver decompensation was associated
with the hepatic infarction. However, caution is war-
ranted when RFA after PEI and/or TAE are planned
to be performed at a site near a large vessel, particu-
larly in patients with limited liver reserve.
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純酒精注射及射頻燒灼術治療肝癌併發大範圍
肝梗塞 — 病例報告
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肝臟梗塞是肝癌射頻燒灼術所造成的少見併發症之一。單一肝動脈或合併門脈系統一
同受損被認為是造成肝臟梗塞的原因。治療肝癌時，射頻燒灼的效果會受鄰近血管的
熱沉效應影響而減低。當腫瘤附近有直徑大於 3 毫米的血管時，為了避免腫瘤燒灼效
果不完全，可考慮在射頻燒灼術前先行於腫瘤鄰近血管處進行純酒精注射術。雖然單
一射頻燒灼術不易造成大血管的損傷，但若之前曾使用其它治療術，如純酒精注射術
或動脈導管栓塞術，則可能造成大血管受損而使肝臟梗塞壞死。我們在此報告一例，
於系列使用三種治療術治療肝癌後，造成左葉肝臟大範圍梗塞之個案。
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